Argenx Se (ARGX) EBT Margin (2016 - 2026)
Argenx Se's (ARGX) quarterly EBT Margin came in at 34.77% in Q2 2026, up 452.0% YoY from 6.3% in Q2 2025, and up 3.04% on a QoQ basis from 33.74% in Q1 2026.
Argenx Se (ARGX) EBT Margin (2016 - 2026) Analysis & Trends
Argenx Se (ARGX) has 11 years of EBT Margin data on file, last reported at 34.77% in Q2 2026.
- Quarterly EBT Margin rose 452.0% year-over-year to 34.77% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 33.58% (up 1189.0% YoY) and the FY2025 annual result came in at 30.1%, up 2632.0% from the prior year.
- EBT Margin improved to 34.77% in Q2 2026, from 33.74% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 34.77% in Q2 2026 to a low of 1087.14% in Q1 2022.
- A 5-year average of 83.18% and a median of 9.74% in 2023 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2022 — EBT Margin sank 110640 bps — and 2023, when it jumped 105220 bps.
- Tracing ARGX's EBT Margin over 5 years: stood at 23.78% in 2022, then surged by 31 bps to 16.34% in 2023, then surged by 170 bps to 11.38% in 2024, then surged by 176 bps to 31.37% in 2025, then advanced by 11 bps to 34.77% in 2026.
- The last three EBT Margin figures came in at 34.77% (Q2 2026), 33.74% (Q1 2026), and 31.37% (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 34.77% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 18.33% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -94.22% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 12.09% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.77% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -2.67% |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | -20,427.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 34.77% |
| Mar 31, 2026 | 33.74% |
| Dec 31, 2025 | 31.37% |
| Sep 30, 2025 | 34.26% |
| Jun 30, 2025 | 30.24% |
| Mar 31, 2025 | 25.62% |
| Dec 31, 2024 | 11.38% |
| Sep 30, 2024 | 15.36% |
| Jun 30, 2024 | -3.14% |
| Mar 31, 2024 | -18.67% |
| Dec 31, 2023 | -16.34% |
| Sep 30, 2023 | -25.31% |
| Jun 30, 2023 | -31.14% |
| Mar 31, 2023 | -34.94% |
| Dec 31, 2022 | -23.78% |
| Sep 30, 2022 | -183.53% |
| Jun 30, 2022 | -289.95% |
| Mar 31, 2022 | -1,087.14% |
| Dec 31, 2021 | 941.05% |
| Sep 30, 2021 | -0.03% |